# BATCH2-THYROID-GATE-1 — Mandatory TSH Gating and Runtime Activation

**Work ID:** `BATCH2-THYROID-GATE-1_mandatory_tsh_gating_and_runtime_activation`  
**Date:** 2026-06-07  
**SOP:** AUTOMATION_BUS_SOP_v1.3.1

---

## Executive verdict

**RUNTIME ACTIVATION COMPLETE.** Mandatory TSH pre-emission gating **implemented, tested, and approved**. **Phase 3 metadata activation** performed after **`APPROVE BATCH2 THYROID GATED ACTIVATION`**. **3/3** eligible thyroid packages **runtime_active_canonical**. **FT3 low** remains formally deferred. **Androgen and eGFR packages untouched.**

---

## Preflight findings

| # | Finding |
|---|---------|
| 1 | `SignalEvaluator.evaluate_all()` emits on `lab_range_exceeded` before override escalation |
| 2 | Override rules are escalation-only — confirmed blocker for thyroid |
| 3 | Pre-emission gate location: after override evaluation, before result append |
| 4 | TSH available via `signal_biomarkers` / lab_ranges |
| 5 | Lab-specific TSH suppression uses existing `lab_range_boundary: below_min` |
| 6 | Files changed: evaluator + 3 signal_library.yaml + tests + governance docs |
| 7 | FT3 low, androgen, eGFR packages untouched |
| 8 | Rollback path documented in execution register |

---

## TSH gating implementation

**Mechanism:** `mandatory_pre_emission_gates` in package `signal_library.yaml`, enforced by `_passes_mandatory_pre_emission_gates()` in `backend/core/analytics/signal_evaluator.py`.

| Package | Gate | Additional fix |
|---------|------|----------------|
| pkg_kb47_free_t3_high | TSH suppressed (`lab_range_boundary: below_min`) | — |
| pkg_kb47_free_t4_high | TSH suppressed (`lab_range_boundary: below_min`) | — |
| pkg_kb47_free_t4_low | TSH present (`comparator_type: biomarker_present`) | `enable_lower_bound: true` |

**Fail-closed:** If gate conditions fail, signal is not appended to results.

---

## STOP gate outcome

**Status:** `RUNTIME_ACTIVATION_COMPLETE`

**Approval received:** **Yes**

**Approval phrase:** `APPROVE BATCH2 THYROID GATED ACTIVATION`

**Approval recorded:** 2026-06-07T15:00:00Z

**Runtime activation performed:** **Yes** — 3 packages activated

---

## Packages activated (Phase 3)

| package_id | gate | post_activation_state |
|------------|------|------------------------|
| pkg_kb47_free_t3_high_t3_predominant_thyrotoxicosis | TSH suppressed | runtime_active_canonical |
| pkg_kb47_free_t4_high_thyrotoxicosis_context | TSH suppressed | runtime_active_canonical |
| pkg_kb47_free_t4_low_thyroid_hormone_deficiency | TSH present | runtime_active_canonical |

**Metadata updated:**
- `medical_frame_identity_index_v1.yaml` — promotion_state, runtime_authority_status, clinical_adjudication_status for three frames
- Three `package_manifest.yaml` — `governance_runtime_activation_*` fields (BATCH2-ACTIVATION-1 pattern)
- `batch2_thyroid_gate_execution_register_v1.yaml` — approval + activation record

---

## Packages deferred

| package_id | reason | activated |
|------------|--------|-----------|
| pkg_kb47_free_t3_low_low_t3_syndrome | thyroid_activation_requires_tsh_ft4_and_illness_medication_context | false |

---

## Excluded packages (10)

Androgen (8) + eGFR (2) — **confirmed untouched** in diff.

---

## Test evidence

### Pre-activation (Phase 2)

Command: `python -m pytest backend/tests/regression/test_batch2_thyroid_tsh_gating.py -q`

```text
11 passed
```

Scenarios covered: FT3 high absent/normal/suppressed TSH; FT4 high absent/normal/suppressed TSH; FT4 low absent/present TSH; FT3 low inactive in frame index; androgen/eGFR inactive; unrelated creatinine signal unaffected.

### Post-activation (Phase 3)

See validation output section below.

---

## Validation output (post-activation)

**Architecture gate:** PASS

```text
architecture_validation_gate: PASS
medical_frame_identity_index: PASS (errors: 0)
context_modifier_catalogue: PASS (errors: 0)
day_one_architecture_validation: PASS
medical_intelligence_architecture_validation: PASS
```

**Frame index validator:** PASS (errors: 0)

**Thyroid gating regression:** PASS

```text
11 passed
```

**Package validators (3 activated thyroid):** all PASS

| package_id | manifest | research | signal | promoted_signal_intelligence |
|------------|----------|----------|--------|------------------------------|
| pkg_kb47_free_t3_high_t3_predominant_thyrotoxicosis | PASS | PASS | PASS | PASS |
| pkg_kb47_free_t4_high_thyrotoxicosis_context | PASS | PASS | PASS | PASS |
| pkg_kb47_free_t4_low_thyroid_hormone_deficiency | PASS | PASS | PASS | PASS |

---

## Rollback path

1. Revert `signal_evaluator.py` gate method and call site  
2. Remove `mandatory_pre_emission_gates` from three signal libraries  
3. Restore FT4 low `enable_lower_bound: false` if rolling back gate fix  
4. Revert frame index + manifest `governance_runtime_activation_*` fields for three activated packages only  
5. Revert `batch2_thyroid_gate_execution_register_v1.yaml` activation flags  

FT3 low, androgen, and eGFR packages remain untouched under rollback.

---

## Carry-forward

| ID | Action |
|----|--------|
| CF-BATCH2-013 | **Resolved** — TSH gating + 3-package metadata activation complete |
| CF-BATCH2-007 | Open — eGFR authority |
| CF-BATCH2-010 | Open — androgen clinical sign-off |
| CF-CONTEXT-MOD-3 | Open — blocks FT3 low illness/medication context |

---

## Confirmations

- No clinical wording changes  
- No threshold value changes  
- No activation keys / signal IDs changed  
- No frontend / SSOT / scoring changes  
- FT3 low not activated  
- Androgen (8) and eGFR (2) packages untouched  

---

## Phase history

| Phase | Status |
|-------|--------|
| Phase 1 — Preflight + STOP gate | Complete |
| Phase 2 — TSH gating implementation + tests | Complete |
| Phase 3 — Metadata runtime activation (post-approval) | Complete |

**Next step:** Post-activation audit evidence review; kernel finish/merge only after human confirmation.
